Production in Australia)

PRODUCTS

OUR PRODUCTS

This information is intended for U.S. residents.

Here you will find a listing of our products available in the U.S.

Consumers should contact their healthcare professional for further advice.
AFLURIA® QUADRIVALENT, Influenza Vaccine Suspension for Intramuscular Injection 

AFLURIA® QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. AFLURIA QUADRIVALENT is approved for use in persons 6 months of age and older

MORE INFORMATION
Product WebsiteImportant Safety InformationDownload Prescribing Information
 
FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) Suspension for Intramuscular Injection 

FLUAD QUADRIVALENTis an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUAD QUADRIVALENT is approved for use in persons 65 years of age and older. Approval is based on the immune response elicited by FLUAD QUADRIVALENT. Data demonstrating a decrease in influenza disease after vaccination with FLUAD QUADRIVALENT are not available.

MORE INFORMATION
Product WebsiteImportant Safety InformationDownload Prescribing Information
 
FLUCELVAX® QUADRIVALENT (Influenza Vaccine) Suspension for Intramuscular Injection 

FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUCELVAX QUADRIVALENT is approved for use in persons 6 months of age and older.

MORE INFORMATION
Product WebsiteImportant Safety InformationDownload Prescribing Information

The trademarks marked ® are registered by CSL Seqirus U.K. Limited or its affiliates in one or more jurisdictions, unless indicated otherwise.

For more information about our products:

If you are a healthcare professional, please click here.

Pandemic Response Solutions

As a global leader in influenza vaccine manufacturing, CSL Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more

 

Important Safety Information for AFLURIA QUADRIVALENT

Consumer

What is AFLURIA® QUADRIVALENT (Influenza Vaccine)?

AFLURIA QUADRIVALENT is a vaccine that helps protect people aged 6 months and older from the flu. Vaccination with any of these may not protect all people who receive the vaccine.

Who should not receive AFLURIA QUADRIVALENT?

You should not get AFLURIA QUADRIVALENT if you have had a severe allergic reaction to any of the ingredients in the vaccine in the past, including egg protein, or a severe allergic reaction to a previous influenza vaccine.

Before receiving AFLURIA QUADRIVALENT, tell your healthcare provider about all medical conditions, including if you:

  • have ever had Guillain-Barré syndrome (severe muscle weakness) within six weeks after getting a flu vaccine. The decision to give any flu vaccine should be made by your healthcare provider, based on careful consideration of the potential benefits and risks.
  • have problems with your immune system or are taking certain medications that suppress your immune system, as these may reduce your immune response to the vaccine
  • have ever fainted when receiving a vaccine

What are the side effects of AFLURIA QUADRIVALENT?

  • pain, tenderness, redness, itching, bruising, and/or swelling where the vaccine was given
  • headache
  • overtiredness with low energy
  • muscle aches
  • feeling unwell (malaise)

Additional side effects in children include:

  • irritability
  • diarrhea
  • changes in eating habits

These are not all the possible side effects of AFLURIA QUADRIVALENT. You can ask your healthcare provider for more information.

What do I do if I have side effects?

Report any severe or unusual side effects to your healthcare provider.

To report SUSPECTED ADVERSE REACTIONS, contact CSL Seqirus USA Inc. at 1-844-275-2461 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.

You are also encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Before receiving this vaccine, please see the full prescribing information for AFLURIA QUADRIVALENT. The information provided here is not comprehensive. To learn more, talk about AFLURIA QUADRIVALENT with your healthcare provider or pharmacist.

AFLURIA® QUADRIVALENT is a registered trademark of Seqirus UK Limited or its affiliates.

Important Safety Information for FLUAD QUADRIVALENT

Consumer

What is FLUAD® QUADRIVALENT?

FLUAD QUADRIVALENT is a vaccine that helps protect against the flu. FLUAD QUADRIVALENT is for people age 65 years and older. Vaccination with FLUAD QUADRIVALENT may not protect all people who receive the vaccine.

Who should not get FLUAD QUADRIVALENT?

You should not get FLUAD QUADRIVALENT if you have had a severe allergic reaction to any of the ingredients in the vaccine in the past, including egg protein, or a severe allergic reaction to a previous influenza vaccine.

Before receiving FLUAD QUADRIVALENT, tell your healthcare provider about all medical conditions, including if you:

  • Have ever had Guillain-Barré syndrome (severe muscle weakness) within six weeks after getting a flu shot. The decision to give FLUAD QUADRIVALENT should be made by your healthcare provider, based on careful consideration of the potential benefits and risks.
  • have problems with your immune system or are taking certain medications that suppress your immune system, as these may reduce your immune response to the vaccine
  • have ever fainted when receiving a vaccine

What are the most common side effects of FLUAD QUADRIVALENT?

  • Pain where shot was given
  • Headache
  • Tiredness

These are not all the possible side effects of FLUAD QUADRIVALENT. You can ask your healthcare provider for a complete list of possible side effects.

What do I do if I have side effects?

Ask your healthcare provider for advice about any side effects that concern you.

To report SUSPECTED ADVERSE REACTIONS, contact CSL Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 and www.vaers.hhs.gov.

You are also encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Before receiving this vaccine, please see the full Prescribing Information for FLUAD QUADRIVALENT. The information provided here is not comprehensive. To learn more, talk about FLUAD QUADRIVALENT with your healthcare provider or pharmacist.

FLUAD® QUADRIVALENT is a registered trademark of Seqirus UK Limited or its affiliates.

Important Safety Information for FLUCELVAX QUADRIVALENT

Consumer

What is FLUCELVAX® QUADRIVALENT (Influenza Vaccine)?

FLUCELVAX QUADRIVALENT is a vaccine that helps protect people aged 6 months and older from the flu. Vaccination with FLUCELVAX QUADRIVALENT may not protect all people who receive the vaccine.

Who should not get FLUCELVAX QUADRIVALENT?

You should not get FLUCELVAX QUADRIVALENT if you have had a severe allergic reaction to any of the ingredients in the vaccine.

Before receiving FLUCELVAX QUADRIVALENT, tell your healthcare provider about all medical conditions, including if you:

  • have ever had Guillain-Barré Syndrome (severe muscle weakness) within six weeks after getting a flu vaccine. The decision to give FLUCELVAX QUADRIVALENT should be made by your healthcare provider, based on careful consideration of the potential benefits and risks.
  • have problems with your immune system or are taking certain medications that suppress your immune system, as these may reduce your immune response to the vaccine
  • have ever fainted when receiving a vaccine

What are the most common side effects of FLUCELVAX QUADRIVALENT?

  • pain, redness, swelling, and/or a raised hardened area where the vaccine was given
  • headache
  • overtiredness with low energy
  • muscle aches
  • feeling unwell (malaise)

Additional side effects seen in children include:

  • tenderness or bruising where vaccine was given
  • sleepiness
  • irritability
  • diarrhea
  • changes in eating habits

These are not all of the possible side effects of FLUCELVAX QUADRIVALENT. You can ask your healthcare provider for more information and for advice about any side effects that concern you.

To report SUSPECTED ADVERSE REACTIONS, contact CSL Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov. You are also encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‐800‐FDA‐1088.

Before receiving this vaccine, please see the full US Prescribing Information for FLUCELVAX QUADRIVALENT. The information provided here does not include all that is known about FLUCELVAX QUADRIVALENT. To learn more, talk with your healthcare provider or pharmacist.

FLUCELVAX® QUADRIVALENT is a registered trademark of Seqirus UK Limited or its affiliates.

US/CORP/0919/0170